{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:39:25Z","timestamp":1775817565708,"version":"3.50.1"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.placenta.2021.12.005","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T11:30:26Z","timestamp":1638790226000},"page":"161-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19?"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3787-5647","authenticated-orcid":false,"given":"Sudha","family":"Warrier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3337-7894","authenticated-orcid":false,"given":"S","family":"Mohana Sundaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lavanya","family":"Varier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ananthakrishnan","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.placenta.2021.12.005_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/JCMA.0000000000000270","article-title":"The outbreak of COVID-19: an overview","volume":"83","author":"Wu","year":"2020","journal-title":"J. Chin. Med. Assoc."},{"issue":"2","key":"10.1016\/j.placenta.2021.12.005_bib2","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/S2213-2600(21)00005-9","article-title":"New variant of SARS-CoV-2 in UK causes surge of COVID-19","volume":"9","author":"Kirby","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"5","key":"10.1016\/j.placenta.2021.12.005_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2591.2011.01990.x","article-title":"The response of human ectomesenchymal dental pulp stem cells to cisplatin treatment","volume":"45","author":"Seifrtova","year":"2012","journal-title":"Int. Endod. J."},{"issue":"2","key":"10.1016\/j.placenta.2021.12.005_bib4","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20150025","article-title":"Human mesenchymal stem cells-current trends and future prospective","volume":"35","author":"Ullah","year":"2015","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.placenta.2021.12.005_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.exer.2012.05.009","article-title":"Human mesenchymal stem cells differentiate into keratocyte-like cells in keratocyte-conditioned medium","volume":"101","author":"Park","year":"2012","journal-title":"Exp. Eye Res."},{"issue":"3","key":"10.1016\/j.placenta.2021.12.005_bib6","first-page":"216","article-title":"Differentiation of mesenchymal stem cell in the microenvironment of retinitis pigmentosa","volume":"3","author":"Huo","year":"2010","journal-title":"Int. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.placenta.2021.12.005_bib7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1136\/gut.2008.154880","article-title":"Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo","volume":"58","author":"Aurich","year":"2009","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.placenta.2021.12.005_bib8","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1152\/physrev.00019.2015","article-title":"Rebuilding the damaged heart: mesenchymal stem cells, cell-based therapy, and engineered heart tissue","volume":"96","author":"Golpanian","year":"2016","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-020-02001-1","article-title":"Mesenchymal stem cells: amazing remedies for bone and cartilage defects","volume":"11","author":"Kangari","year":"2020","journal-title":"Stem Cell Res. Ther."},{"issue":"21","key":"10.1016\/j.placenta.2021.12.005_bib10","doi-asserted-by":"crossref","first-page":"8089","DOI":"10.1074\/jbc.RA118.001739","article-title":"Smooth muscle cells differentiated from mesenchymal stem cells are regulated by microRNAs and suitable for vascular tissue grafts","volume":"293","author":"Gu","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"121","key":"10.1016\/j.placenta.2021.12.005_bib11","first-page":"e33","article-title":"Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches","volume":"20","author":"Augello","year":"2010","journal-title":"Eur. Cell. Mater."},{"issue":"11","key":"10.1016\/j.placenta.2021.12.005_bib12","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1634\/stemcells.2007-0197","article-title":"Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing","volume":"25","author":"Chamberlain","year":"2007","journal-title":"Stem cells"},{"issue":"3","key":"10.1016\/j.placenta.2021.12.005_bib13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","article-title":"A perivascular origin for mesenchymal stem cells in multiple human organs","volume":"3","author":"Crisan","year":"2008","journal-title":"Cell stem cell"},{"issue":"4","key":"10.1016\/j.placenta.2021.12.005_bib14","first-page":"315","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells","volume":"8","author":"Dominici","year":"2006","journal-title":"Int. Soc. Cell. Ther. Position Stat. Cytother."},{"issue":"9","key":"10.1016\/j.placenta.2021.12.005_bib15","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.placenta.2021.12.005_bib16","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/stem.1681","article-title":"Concise review: the surface markers and identity of human mesenchymal stem cells","volume":"32","author":"Lv","year":"2014","journal-title":"Stem cells"},{"issue":"6","key":"10.1016\/j.placenta.2021.12.005_bib17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/14653240601045399","article-title":"Mesenchymal stromal cells: tissue repair and immune modulation","volume":"8","author":"Le Blanc","year":"2006","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02504-8","article-title":"Mesenchymal stem cell mediates cardiac repair through autocrine, paracrine and endocrine axes","volume":"18","author":"Sid-Otmane","year":"2020","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.placenta.2021.12.005_bib19","doi-asserted-by":"crossref","first-page":"165624","DOI":"10.1016\/j.bbadis.2019.165624","article-title":"Stem cells for treatment of musculoskeletal conditions-orthopaedic\/sports medicine applications","volume":"1866","author":"Zumwalt","year":"2020","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4062\/biomolther.2019.065","article-title":"Differentiation of human mesenchymal stem cells towards neuronal lineage: clinical trials in nervous system disorders","volume":"28","author":"Hern\u00e1ndez","year":"2020","journal-title":"Biomol. Therapeut."},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10238-013-0266-1","article-title":"Novel therapy for insulin-dependent diabetes mellitus: infusion of in vitro-generated insulin-secreting cells","volume":"15","author":"Dave","year":"2015","journal-title":"Clin. Exp. Med."},{"issue":"sup2","key":"10.1016\/j.placenta.2021.12.005_bib22","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1080\/21691401.2018.1479709","article-title":"Comparison of conventional and advanced in vitro models in the toxicity testing of nanoparticles","volume":"46","author":"Fr\u00f6hlich","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"8","key":"10.1016\/j.placenta.2021.12.005_bib23","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1046\/j.1432-1327.2001.02140.x","article-title":"Multisite control of the Crabtree effect in ascites hepatoma cells","volume":"268","author":"Rodr\u00edguez\u2010Enr\u00edquez","year":"2001","journal-title":"Eur. J. Biochem."},{"issue":"2","key":"10.1016\/j.placenta.2021.12.005_bib24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/toxsci\/kfm052","article-title":"Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants","volume":"97","author":"Marroquin","year":"2007","journal-title":"Toxicol. Sci."},{"issue":"18","key":"10.1016\/j.placenta.2021.12.005_bib25","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.2174\/138161212800492859","article-title":"Stem cells as a novel tool for drug screening and treatment of degenerative diseases","volume":"18","author":"Zuba-Surma","year":"2012","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.placenta.2021.12.005_bib26","doi-asserted-by":"crossref","first-page":"102207","DOI":"10.1016\/j.scr.2021.102207","article-title":"Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery","volume":"53","author":"Giani","year":"2021","journal-title":"Stem Cell Res."},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-019-1397-4","article-title":"iPSC-derived MSC therapy induces immune tolerance and supports long-term graft survival in mouse orthotopic tracheal transplants","volume":"10","author":"Khan","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.placenta.2021.12.005_bib28","first-page":"2018","article-title":"Generation and applications of induced pluripotent stem cell-derived mesenchymal stem cells","author":"Zhao","year":"2018","journal-title":"Stem Cell. Int."},{"issue":"7","key":"10.1016\/j.placenta.2021.12.005_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.placenta.2021.12.005_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.placenta.2021.12.005_bib31","series-title":"Pathogenesis of COVID-19 from a Cell Biology Perspective","author":"Mason","year":"2020"},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.virol.2007.09.045","article-title":"SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells","volume":"372","author":"Mossel","year":"2008","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.placenta.2021.12.005_bib33","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1165\/rcmb.2012-0339OC","article-title":"Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus","volume":"48","author":"Qian","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.placenta.2021.12.005_bib34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1515\/jtim-2016-0012","article-title":"Acute respiratory distress syndrome: an update and review","volume":"6","author":"Rawal","year":"2018","journal-title":"J. Transl. Int. Med."},{"issue":"Supplement 4","key":"10.1016\/j.placenta.2021.12.005_bib35","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1513\/AnnalsATS.201808-534MG","article-title":"Cell-based therapy for chronic obstructive pulmonary disease. Rebuilding the lung","volume":"15","author":"Weiss","year":"2018","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"12","key":"10.1016\/j.placenta.2021.12.005_bib36","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1038\/mt.2011.152","article-title":"The development of a novel cancer immunotherapeutic platform using tumor-targeting mesenchymal stem cells and a protein vaccine","volume":"19","author":"Wei","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.placenta.2021.12.005_bib37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fcimb.2012.00140","article-title":"Mesenchymal stem cells as a novel vaccine platform","volume":"2","author":"Tomchuck","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.placenta.2021.12.005_bib38","series-title":"Engineered Human Mesenchymal Stem Cells as New Vaccine Platform for COVID-19","author":"Liu","year":"2020"},{"issue":"12","key":"10.1016\/j.placenta.2021.12.005_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243705","article-title":"Efficacy and harms of remdesivir for the treatment of COVID-19: a systematic review and meta-analysis","volume":"15","author":"Piscoya","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.placenta.2021.12.005_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6175964","article-title":"Pulmonary fibrosis in COVID-19 survivors: predictive factors and risk reduction strategies","volume":"2020","author":"Ojo","year":"2020","journal-title":"Pulmonary Med."},{"key":"10.1016\/j.placenta.2021.12.005_bib41","first-page":"2020","article-title":"Cytokine storm in COVID-19 patients, its impact on organs and potential treatment by QTY code-designed detergent-free chemokine receptors","author":"Mustafa","year":"2020","journal-title":"Mediat. Inflamm."},{"issue":"10223","key":"10.1016\/j.placenta.2021.12.005_bib42","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-020-01849-7","article-title":"The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm","volume":"11","author":"Kavianpour","year":"2020","journal-title":"Stem Cell Res. Ther."},{"issue":"10","key":"10.1016\/j.placenta.2021.12.005_bib44","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/sctm.20-0186","article-title":"Current status of mesenchymal stem cell therapy for immune\/inflammatory lung disorders: gleaning insights for possible use in COVID\u201019","volume":"9","author":"Yen","year":"2020","journal-title":"Stem Cells Transl. Med."},{"issue":"6287","key":"10.1016\/j.placenta.2021.12.005_bib45","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.aaf6116","article-title":"Zika virus impairs growth in human neurospheres and brain organoids","volume":"352","author":"Garcez","year":"2016","journal-title":"Science (New York, N.Y.)"},{"issue":"2","key":"10.1016\/j.placenta.2021.12.005_bib46","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.stem.2016.04.014","article-title":"Zika virus depletes neural progenitors in human cerebral organoids through activation of the innate immune receptor TLR3","volume":"19","author":"Dang","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.placenta.2021.12.005_bib47","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.cell.2016.04.032","article-title":"Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure","volume":"165","author":"Qian","year":"2016","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.placenta.2021.12.005_bib48","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1042\/CBI20110026","article-title":"Bone marrow mesenchymal stem cells can differentiate into type II alveolar epithelial cells in vitro","volume":"35","author":"Ma","year":"2011","journal-title":"Cell Biol. Int."},{"issue":"05.05.079095","key":"10.1016\/j.placenta.2021.12.005_bib49","article-title":"Identification of candidate COVID-19 therapeutics using hPSC-derived lung organoids","author":"Han","year":"2020","journal-title":"BioRxiv"},{"issue":"7841","key":"10.1016\/j.placenta.2021.12.005_bib50","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2901-9","article-title":"Identification of SARS-CoV-2 inhibitors using lung and colonic organoids","volume":"589","author":"Han","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.placenta.2021.12.005_bib51","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.stem.2020.11.009","article-title":"Androgen signaling regulates SARS-CoV-2 receptor levels and is associated with severe COVID-19 symptoms in men","volume":"27","author":"Samuel","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.placenta.2021.12.005_bib52","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.stem.2020.10.005","article-title":"Human lung stem cell-based alveolospheres provide insights into SARS-CoV-2-mediated interferon responses and pneumocyte dysfunction","volume":"27","author":"Katsura","year":"2020","journal-title":"Cell stem cell"},{"key":"10.1016\/j.placenta.2021.12.005_bib53","series-title":"Adult Stem Cell-Derived Complete Lung Organoid Models Emulate Lung Disease in COVID-19, bioRxiv : the Preprint Server for Biology","author":"Tindle","year":"2021"},{"issue":"5","key":"10.1016\/j.placenta.2021.12.005_bib54","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020105912","article-title":"An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells","volume":"40","author":"Lamers","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.placenta.2021.12.005_bib55","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26575","article-title":"Human embryonic lung epithelial tips are multipotent progenitors that can be expanded in vitro as long-term self-renewing organoids","volume":"6","author":"Nikoli\u0107","year":"2017","journal-title":"eLife"},{"issue":"4","key":"10.1016\/j.placenta.2021.12.005_bib56","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jcmgh.2020.11.003","article-title":"Drug inhibition of SARS-CoV-2 replication in human pluripotent stem cell\u2013derived intestinal organoids","volume":"11","author":"Kr\u00fcger","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1634\/stemcells.2007-0563","article-title":"Toll\u2010like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses","volume":"26","author":"Tomchuck","year":"2008","journal-title":"Stem cells"},{"issue":"11","key":"10.1016\/j.placenta.2021.12.005_bib58","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/01.inf.0000145815.70485.f7","article-title":"Coronaviruses: from common colds to severe acute respiratory syndrome","volume":"23","author":"Baker","year":"2004","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.placenta.2021.12.005_bib59","article-title":"Strategies to enhance mesenchymal stem cell-based therapies for acute respiratory distress syndrome","volume":"2019","author":"Han","year":"2019","journal-title":"Stem Cell. Int."},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib60","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1186\/s12879-020-05525-2","article-title":"Bone marrow-derived mesenchymal stem cells attenuate pulmonary inflammation and lung damage caused by highly pathogenic avian influenza A\/H5N1 virus in BALB\/c mice","volume":"20","author":"Yudhawati","year":"2020","journal-title":"BMC Infect. Dis."},{"issue":"13","key":"10.1016\/j.placenta.2021.12.005_bib61","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1073\/pnas.1601911113","article-title":"Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo","volume":"113","author":"Chan","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"2","key":"10.1016\/j.placenta.2021.12.005_bib62","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/infdis\/jiy478","article-title":"Therapeutic implications of human umbilical cord mesenchymal stromal cells in attenuating influenza A (H5N1) virus\u2013associated acute lung injury","volume":"219","author":"Loy","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.placenta.2021.12.005_bib63","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.reth.2019.07.009","article-title":"Effects of Wharton's jelly-derived mesenchymal stem cells on chronic obstructive pulmonary disease","volume":"11","author":"Cho","year":"2019","journal-title":"Regenrat. Ther."},{"issue":"5","key":"10.1016\/j.placenta.2021.12.005_bib64","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jpeds.2013.12.011","article-title":"Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial","volume":"164","author":"Chang","year":"2014","journal-title":"J. Pediatr."},{"issue":"12","key":"10.1016\/j.placenta.2021.12.005_bib65","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S2213-2600(14)70217-6","article-title":"Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis","volume":"2","author":"Walter","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib66","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13287-019-1169-1","article-title":"Overexpressing p130\/E2F4 in mesenchymal stem cells facilitates the repair of injured alveolar epithelial cells in LPS-induced ARDS mice","volume":"10","author":"Zhang","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.placenta.2021.12.005_bib67","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s13287-015-0257-0","article-title":"Synergism of MSC-secreted HGF and VEGF in stabilising endothelial barrier function upon lipopolysaccharide stimulation via the Rac1 pathway","volume":"6","author":"Yang","year":"2015","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.placenta.2021.12.005_bib68","first-page":"7873625","article-title":"Comparative effects of umbilical cord- and menstrual blood-derived MSCs in repairing acute lung injury","volume":"2018","author":"Ren","year":"2018","journal-title":"Stem Cell. Int."},{"issue":"6","key":"10.1016\/j.placenta.2021.12.005_bib69","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00858-2020","article-title":"Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19","volume":"55","author":"Khoury","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.placenta.2021.12.005_bib70","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/0963689719837897","article-title":"The pros and cons of mesenchymal stem cell-based therapies","volume":"28","author":"Musia\u0142-Wysocka","year":"2019","journal-title":"Cell Transplant."},{"issue":"11","key":"10.1016\/j.placenta.2021.12.005_bib71","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/cbin.11440","article-title":"Stem cell therapy for COVID\u201019: possibilities and challenges","volume":"44","author":"Choudhery","year":"2020","journal-title":"Cell Biol. Int."},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib72","first-page":"1","article-title":"Challenges and translational considerations of mesenchymal stem\/stromal cell therapy for Parkinson's disease","volume":"5","author":"Fri\u010dov\u00e1","year":"2020","journal-title":"NPJ Regenerat. Med."},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib73","first-page":"1","article-title":"Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial","volume":"6","author":"Shi","year":"2021","journal-title":"Signal Trans. Target. Ther."},{"issue":"12","key":"10.1016\/j.placenta.2021.12.005_bib74","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12947","article-title":"Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID-19 pneumonia: a pilot study","volume":"53","author":"Feng","year":"2020","journal-title":"Cell Prolif"},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib75","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s13054-020-03142-8","article-title":"Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia","volume":"24","author":"Guo","year":"2020","journal-title":"Crit. Care"},{"issue":"2","key":"10.1016\/j.placenta.2021.12.005_bib76","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis."},{"key":"10.1016\/j.placenta.2021.12.005_bib77","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-virology-031413-085537","article-title":"IFITM-family proteins: the cell's first line of antiviral defense","volume":"1","author":"Bailey","year":"2014","journal-title":"Annu. Rev. Virol."},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib78","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12015-020-10032-7","article-title":"Mesenchymal stromal cells in viral infections: implications for COVID-19","volume":"17","author":"Rocha","year":"2021","journal-title":"Stem Cell Rev. Rep."},{"issue":"17","key":"10.1016\/j.placenta.2021.12.005_bib79","doi-asserted-by":"crossref","first-page":"9654","DOI":"10.1073\/pnas.160270697","article-title":"Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates","volume":"97","author":"Lin","year":"2000","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"10","key":"10.1016\/j.placenta.2021.12.005_bib80","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/aps.2013.121","article-title":"Characteristics of human infection with avian influenza viruses and development of new antiviral agents","volume":"34","author":"Liu","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emi.2013.52","article-title":"Reduction of influenza virus-induced lung inflammation and mortality in animals treated with a phosophodisestrase-4 inhibitor and a selective serotonin reuptake inhibitor","volume":"2","author":"Sharma","year":"2013","journal-title":"Emerg. Microb. Infect."},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-016-0395-z","article-title":"Mesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in mice","volume":"7","author":"Li","year":"2016","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.placenta.2021.12.005_bib83","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.biocel.2019.02.001","article-title":"Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: development of 3D primed therapeutic MSCs","volume":"110","author":"Mandal","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib84","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.canlet.2013.02.019","article-title":"Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth","volume":"335","author":"Katakowski","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.placenta.2021.12.005_bib85","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.omtn.2018.01.010","article-title":"miR-93-5p-Containing exosomes treatment attenuates acute myocardial infarction-induced myocardial damage, molecular therapy","volume":"11","author":"Liu","year":"2018","journal-title":"Nucl. Acids"},{"issue":"8","key":"10.1016\/j.placenta.2021.12.005_bib86","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1093\/ndt\/gfs168","article-title":"Therapeutic potential of mesenchymal stem cell-derived microvesicles","volume":"27","author":"Biancone","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"10.1016\/j.placenta.2021.12.005_bib87","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.3390\/ijms15034142","article-title":"Exosomes derived from mesenchymal stem cells","volume":"15","author":"Yu","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib88","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/acsnano.6b07607","article-title":"Re-engineering extracellular vesicles as smart nanoscale therapeutics","volume":"11","author":"Armstrong","year":"2017","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.placenta.2021.12.005_bib89","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/j.1600-0854.2011.01225.x","article-title":"Exosome secretion: molecular mechanisms and roles in immune responses","volume":"12","author":"Bobrie","year":"2011","journal-title":"Traffic"},{"issue":"4","key":"10.1016\/j.placenta.2021.12.005_bib90","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2174\/156652312802083594","article-title":"Exosomes and the emerging field of exosome-based gene therapy","volume":"12","author":"O'Loughlin","year":"2012","journal-title":"Curr. Gene Ther."},{"issue":"6","key":"10.1016\/j.placenta.2021.12.005_bib91","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"issue":"D1","key":"10.1016\/j.placenta.2021.12.005_bib92","doi-asserted-by":"crossref","first-page":"D1241","DOI":"10.1093\/nar\/gkr828","article-title":"ExoCarta 2012: database of exosomal proteins, RNA and lipids","volume":"40","author":"Mathivanan","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.placenta.2021.12.005_bib93","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1089\/scd.2013.0479","article-title":"Mesenchymal stem cells secrete immunologically active exosomes","volume":"23","author":"Zhang","year":"2014","journal-title":"Stem Cell. Dev."},{"issue":"2","key":"10.1016\/j.placenta.2021.12.005_bib94","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1189\/jlb.3RU0513-292RR","article-title":"Microvesicles: ubiquitous contributors to infection and immunity","volume":"97","author":"Lai","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"11","key":"10.1016\/j.placenta.2021.12.005_bib95","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.bcp.2011.12.037","article-title":"The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities","volume":"83","author":"Pant","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.placenta.2021.12.005_bib96","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2013.10.015","article-title":"HCV transmission by hepatic exosomes establishes a productive infection","volume":"60","author":"Cosset","year":"2014","journal-title":"J. Hepatol."},{"issue":"46","key":"10.1016\/j.placenta.2021.12.005_bib97","doi-asserted-by":"crossref","first-page":"E4991","DOI":"10.1073\/pnas.1419338111","article-title":"Cells infected with herpes simplex virus 1 export to uninfected cells exosomes containing STING, viral mRNAs, and microRNAs","volume":"111","author":"Kalamvoki","year":"2014","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"4","key":"10.1016\/j.placenta.2021.12.005_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004780","article-title":"TGF-\u03b2 suppression of HBV RNA through AID-dependent recruitment of an RNA exosome complex","volume":"11","author":"Liang","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.placenta.2021.12.005_bib99","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.virol.2015.03.040","article-title":"Exosomes in human semen restrict HIV-1 transmission by vaginal cells and block intravaginal replication of LP-BM5 murine AIDS virus complex","volume":"482","author":"Madison","year":"2015","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.placenta.2021.12.005_bib100","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.addr.2012.07.001","article-title":"Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery","volume":"65","author":"Yeo","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib101","first-page":"17","article-title":"Exosome and exosomal microRNA: trafficking, sorting, and function","volume":"13","author":"Zhang","year":"2015","journal-title":"Dev. Reprod. Biol."},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms8321","article-title":"Exosome-delivered microRNAs modulate the inflammatory response to endotoxin","volume":"6","author":"Alexander","year":"2015","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib103","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/1873-3468.12024","article-title":"Exosomes derived from mineralizing osteoblasts promote ST2 cell osteogenic differentiation by alteration of microRNA expression","volume":"590","author":"Cui","year":"2016","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.placenta.2021.12.005_bib104","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40364-019-0159-x","article-title":"Exosomes from mesenchymal stem\/stromal cells: a new therapeutic paradigm","volume":"7","author":"Yin","year":"2019","journal-title":"Biomark. Res."},{"issue":"3","key":"10.1016\/j.placenta.2021.12.005_bib105","doi-asserted-by":"crossref","first-page":"293","DOI":"10.15171\/apb.2016.041","article-title":"Mesenchymal stem cell-derived exosomes: new opportunity in cell-free therapy","volume":"6","author":"Sarvar","year":"2016","journal-title":"Adv. Pharmaceut. Bull."},{"issue":"9","key":"10.1016\/j.placenta.2021.12.005_bib106","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.5966\/sctm.2015-0348","article-title":"Exosomal microRNAs derived from umbilical mesenchymal stem cells inhibit hepatitis C virus infection","volume":"5","author":"Qian","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.placenta.2021.12.005_bib107","series-title":"Nebulization Therapy with Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Pneumonia","author":"Chu","year":"2021"},{"issue":"12","key":"10.1016\/j.placenta.2021.12.005_bib108","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1089\/scd.2020.0080","article-title":"Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19","volume":"29","author":"Sengupta","year":"2020","journal-title":"Stem Cell. Dev."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400421006548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400421006548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T18:07:21Z","timestamp":1758910041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400421006548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":108,"alternative-id":["S0143400421006548"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2021.12.005","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19?","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2021.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}